{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:51:20Z","timestamp":1781790680357,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,18]]},"DOI":"10.7759\/cureus.111085","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:57:42Z","timestamp":1781787462000},"source":"Crossref","is-referenced-by-count":0,"title":["Diffuse Large B-Cell Lymphoma Masquerading as Recurrent Pleural Effusion and Melena: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Priyal","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smitesh","family":"Padte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya Kumar","family":"Damodaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Parvathaneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-cell lymphoma","volume":"384","author":"Sehn LH","year":"2021","unstructured":"Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med. 2021, 384:842-58. 10.1056\/NEJMra2027612","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13172767","article-title":"Endoscopic and histopathological characteristics of gastrointestinal lymphoma: A multicentric study","volume":"13","author":"Tran QT","year":"2023","unstructured":"Tran QT, Nguyen Duy T, Nguyen-Tran BS, et al.. Endoscopic and histopathological characteristics of gastrointestinal lymphoma: A multicentric study. Diagnostics (Basel). 2023, 13:2767. 10.3390\/diagnostics13172767","journal-title":"Diagnostics (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2687291","article-title":"Diffuse large B cell lymphoma with cutaneous and gastrointestinal involvement","volume":"2022","author":"Kyaw AM","year":"2022","unstructured":"Kyaw AM, Aye TT, Htun LL. Diffuse large B cell lymphoma with cutaneous and gastrointestinal involvement. Case Rep Gastrointest Med. 2022, 2022:2687291. 10.1155\/2022\/2687291","journal-title":"Case Rep Gastrointest Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2025.07.2881","article-title":"Primary pulmonary diffuse large B-cell lymphoma presenting as recurrent pleural effusions","volume":"168","author":"Sivakolundu K","year":"2025","unstructured":"Sivakolundu K, Bechara S. Primary pulmonary diffuse large B-cell lymphoma presenting as recurrent pleural effusions. Chest. 2025, 168:A5135-6. 10.1016\/j.chest.2025.07.2881","journal-title":"Chest"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65991","article-title":"A curious case of pericardial effusion diagnosed as diffuse large B-cell lymphoma","volume":"16","author":"Mahashabde ML","year":"2024","unstructured":"Mahashabde ML, Bhavsar HM, Bhimani YR. A curious case of pericardial effusion diagnosed as diffuse large B-cell lymphoma. Cureus. 2024, 16:e65991. 10.7759\/cureus.65991","journal-title":"Cureus"},{"key":"ref6","article-title":"Ascites with bilateral ovarian masses and peritoneal carcinomatosis as a unique presentation of high-grade B-cell lymphoma","volume":"Abstract 0508","author":"Andrews LE","year":"2025","unstructured":"Andrews LE, Bressman M. Ascites with bilateral ovarian masses and peritoneal carcinomatosis as a unique presentation of high-grade B-cell lymphoma. J Hosp Med. 2025, Abstract 0508:","journal-title":"J Hosp Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2022.05.16","article-title":"Lymphoproliferative disorder involving body fluid: Diagnostic approaches and roles of ancillary studies","volume":"56","author":"Koh J","year":"2022","unstructured":"Koh J, Shin SA, Lee JA, Jeon YK. Lymphoproliferative disorder involving body fluid: Diagnostic approaches and roles of ancillary studies. J Pathol Transl Med. 2022, 56:173-86. 10.4132\/jptm.2022.05.16","journal-title":"J Pathol Transl Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.5516-20","article-title":"Massive ascites caused by primary diffuse large B-cell lymphoma of the jejunum: A case of a rare initial symptom","volume":"60","author":"Ota K","year":"2021","unstructured":"Ota K, Nishida S, Akutagawa H, et al.. Massive ascites caused by primary diffuse large B-cell lymphoma of the jejunum: A case of a rare initial symptom. Intern Med. 2021, 60:397-402. 10.2169\/internalmedicine.5516-20","journal-title":"Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65222","article-title":"An unusual presentation of diffuse large B-cell lymphoma with penile metastasis","volume":"16","author":"Yella PR","year":"2024","unstructured":"Yella PR, Jagani PP, Patel V, Jagani RP, Ramesh V, Skaria PE, Chandra A. An unusual presentation of diffuse large B-cell lymphoma with penile metastasis. Cureus. 2024, 16:e65222. 10.7759\/cureus.65222","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12527","article-title":"An atypical presentation of diffuse large B-cell lymphoma","volume":"13","author":"Garc\u00eas Soares S","year":"2021","unstructured":"Garc\u00eas Soares S, Martins Mendes T, Couto C, Pereira Anjos D, S\u00e1 AJ. An atypical presentation of diffuse large B-cell lymphoma. Cureus. 2021, 13:e12527. 10.7759\/cureus.12527","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A6975","article-title":"Diffuse large B-cell lymphoma presenting as recurrent pleural effusion in a 94-year-old woman with metastatic colon cancer","volume":"211","author":"Itmam A","year":"2025","unstructured":"Itmam A, Ahmed U. Diffuse large B-cell lymphoma presenting as recurrent pleural effusion in a 94-year-old woman with metastatic colon cancer. Am J Respir Crit Care Med. 2025, 211:A6975. 10.1164\/ajrccm.2025.211.Abstracts.A6975","journal-title":"Am J Respir Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-2026-1-0125","article-title":"B-cell lymphoma initially presenting as isolated pleural effusion: A challenging diagnostic case report","volume":"15","author":"Chen Y","year":"2026","unstructured":"Chen Y, Hao Y, Zhao W, Zhang N, Zhou Y. B-cell lymphoma initially presenting as isolated pleural effusion: A challenging diagnostic case report. Transl Cancer Res. 2026, 15:135. 10.21037\/tcr-2026-1-0125","journal-title":"Transl Cancer Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP6LXA2LKFZAMC","article-title":"Malignant effusions correlate with poorer prognosis in patients with diffuse large B-cell lymphoma","volume":"143","author":"Chen YP","year":"2015","unstructured":"Chen YP, Huang HY, Lin KP, Medeiros LJ, Chen TY, Chang KC. Malignant effusions correlate with poorer prognosis in patients with diffuse large B-cell lymphoma. Am J Clin Pathol. 2015, 143:707-15. 10.1309\/AJCP6LXA2LKFZAMC","journal-title":"Am J Clin Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-025-06686-3","article-title":"Diffuse large B-cell lymphoma in the new era: Prognostic tools for mapping risk","volume":"104","author":"Duminuco A","year":"2025","unstructured":"Duminuco A, Scarso S, Del Fabro V, et al.. Diffuse large B-cell lymphoma in the new era: Prognostic tools for mapping risk. Ann Hematol. 2025, 104:4897-911. 10.1007\/s00277-025-06686-3","journal-title":"Ann Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-026-01458-2","article-title":"Current treatment algorithm: Diffuse large B cell lymphoma","volume":"16","author":"Ansell SM","year":"2026","unstructured":"Ansell SM, Nowakowski GS. Current treatment algorithm: Diffuse large B cell lymphoma. Blood Cancer J. 2026, 16:10.1038\/s41408-026-01458-2","journal-title":"Blood Cancer J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2991\/chi.d.200410.001","article-title":"Cost analysis of R-CHOP versus dose-adjusted R-EPOCH in treatment of diffuse large B-cell lymphoma with high-risk features","volume":"2","author":"Dholaria B","year":"2020","unstructured":"Dholaria B, Vanegas YA, Diehl N, et al.. Cost analysis of R-CHOP versus dose-adjusted R-EPOCH in treatment of diffuse large B-cell lymphoma with high-risk features. Clin Hematol Int. 2020, 2:117-24. 10.2991\/chi.d.200410.001","journal-title":"Clin Hematol Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-200776","article-title":"Pola-R-CHP regimen for frontline therapy in diffuse large B cell lymphoma with high-risk factors","volume":"144","author":"Zhao X","year":"2024","unstructured":"Zhao X, Liu Z. Pola-R-CHP regimen for frontline therapy in diffuse large B cell lymphoma with high-risk factors. Blood. 2024, 144:6430. 10.1182\/blood-2024-200776","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025017092","article-title":"A multicenter phase 1\/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL","volume":"9","author":"Cahill K","year":"2025","unstructured":"Cahill K, Godfrey J, Nabhan C, et al.. A multicenter phase 1\/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL. Blood Adv. 2025, 9:5665-75. 10.1182\/bloodadvances.2025017092","journal-title":"Blood Adv"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(24)01525-8","article-title":"ABCL-406 Real-world sequential use of CD19-directed therapies for relapsed or refractory (R\/R) diffuse large B-cell lymphoma (DLBCL): Tafasitamab preceding chimeric antigen receptor T-cell (CAR-T) therapy","volume":"24","author":"Epperla N","year":"2024","unstructured":"Epperla N, Nastoupil LJ, Feinberg B, et al.. ABCL-406 Real-world sequential use of CD19-directed therapies for relapsed or refractory (R\/R) diffuse large B-cell lymphoma (DLBCL): Tafasitamab preceding chimeric antigen receptor T-cell (CAR-T) therapy. Clin Lymphoma Myeloma Leuk. 2024, 24:S477. 10.1016\/S2152-2650(24)01525-8","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19860","article-title":"Sequencing of therapy for patients with diffuse large B-cell lymphoma in the era of novel drugs","volume":"205","author":"Karsten IE","year":"2024","unstructured":"Karsten IE, Shumilov E, Schmitz N, Lenz G. Sequencing of therapy for patients with diffuse large B-cell lymphoma in the era of novel drugs. Br J Haematol. 2024, 205:2163-74. 10.1111\/bjh.19860","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/499340-diffuse-large-b-cell-lymphoma-masquerading-as-recurrent-pleural-effusion-and-melena-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:57:42Z","timestamp":1781787462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/499340-diffuse-large-b-cell-lymphoma-masquerading-as-recurrent-pleural-effusion-and-melena-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.111085","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}